Mariposa Health Overview

  • Founded
  • 2008

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Mariposa Health General Information

Description

Developer of pharmaceutical technology and products intended for the treatment of conditions causing chronically poor airflow to the lungs. The company's health and pharmaceutical research and development provide a pronged complementary approach through anti-inflammatory/anti-oxidant and an oral bacterial vaccine for the treatment of Chronic Obstructive Pulmonary Disease (COPD) from its early to severe stages, enabling patients to get treatment for lung and inflammatory conditions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Mariposa Health US
Primary Office
  • 61 Avalon Parade
  • Unit 6
  • Avalon Beach, New South Wales 2107
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mariposa Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mariposa Health‘s full profile, request access.

Request a free trial

Mariposa Health Patents

Mariposa Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20060235045-A1 Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same Active 30-Jul-2003 00000000000 0
AU-2004261527-A1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same Active 30-Jul-2003 00000000000
CA-2533919-A1 Therapeutic agent for chronic obstructive pulmonary disease and method for treating chronic obstructive pulmonary disease using the same Active 30-Jul-2003 00000000000
CA-2533919-C Therapeutic agent for chronic obstructive pulmonary disease and method for treating chronic obstructive pulmonary disease using the same Inactive 30-Jul-2003 00000000000
EP-1650191-A1 Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same Active 30-Jul-2003 A61K31/4704
To view Mariposa Health’s complete patent history, request access »

Mariposa Health Executive Team (1)

Name Title Board Seat Contact Info
Phillip Comans Managing Director, Executive Chairman, Founder & President
To view Mariposa Health’s complete executive team members history, request access »

Mariposa Health Board Members (1)

Name Representing Role Since
0000000 000000 Mariposa Health Managing Director, Executive Chairman, Founder & President 000 0000
To view Mariposa Health’s complete board members history, request access »